Cipla informs about acquisition

06 Jan 2024 Evaluate
Cipla has informed that Cipla (EU), wholly owned subsidiary of the Company in UK, has entered into a joint venture agreement with Kemwell Biopharma UK and MNI Ventures, Mauritius on 5th January, 2024 for incorporation of a joint venture company in USA.

The above information is a part of company’s filings submitted to BSE.

Cipla Share Price

1391.20 -6.75 (-0.48%)
19-Jan-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1673.55
Dr. Reddys Lab 1166.45
Cipla 1391.20
Zydus Lifesciences 881.10
Lupin 2178.20
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×